Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Fentanyl Sublingual Spray vs IV in Opioid Naive Subjects
NCT02576353Phase 1Completed
- Sponsor
- Insys Therapeutics
- Start
- Oct 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fentanyl (transdermal patch + oral transmucosal lozenge) in pain (5 cohorts), sponsored by Insys Therapeutics. Primary endpoints: Maximum concentration, Time to maximum concentration and 6 more. Started Oct 2015; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
pain
Beyond the preview
Go deeper on NCT02576353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576353.